[1]王悦舒,张梅.调节性B细胞与1型糖尿病[J].国际内分泌代谢杂志,2017,37(03):195-198.[doi:10.3760/cma.j.issn.1673-4157.2017.03.014]
　Wang Yueshu,Zhang Mei..Regulatory B cells and type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2017,37(03):195-198.[doi:10.3760/cma.j.issn.1673-4157.2017.03.014]
点击复制

调节性B细胞与1型糖尿病()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年03期
页码:
195-198
栏目:
综述
出版日期:
2017-05-20

文章信息/Info

Title:
Regulatory B cells and type 1 diabetes
作者:
王悦舒; 张梅
210029 南京医科大学第一附属医院内分泌科
Author(s):
Wang Yueshu;  Zhang Mei.
Department of Endocrinology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
关键词:
调节性B细胞;  1型糖尿病;  自身免疫性疾病
Keywords:
Regulatory B cells;  Type 1 diabetes mellitus;  Autoimmune diseases
DOI:
10.3760/cma.j.issn.1673-4157.2017.03.014
摘要:
1型糖尿病主要是由T细胞介导的针对胰岛β细胞的自身免疫性疾病,然而B细胞在1型糖尿病发生、发展中也发挥重要作用,B细胞去除可用于治疗1型糖尿病。调节性B细胞是近来研究发现的一群具有免疫负向调控作用的B细胞亚群。在1型糖尿病中存在调节性B细胞数量和功能的异常。探索调节性B细胞在1型糖尿病发病机制中所起的作用将提供更多的理论依据,为1型糖尿病免疫治疗提供新靶点和新思路。
Abstract:
Type 1 diabetes mellitus(T1DM)is an autoimmune disorder characterized by the T cell-mediated destruction of islet β cells. However, B cells also play critical roles in the occurrence and development of T1DM. B cells depletion could be used in the treatment of T1DM. To date, regulatory B cells(Bregs), as immunosuppressive B cells, have been shown to play pivotal roles in the control of autoimmunity and pathological immune responses. Bregs are numerically and functionally impaired in T1DM. Investigation of Bregs in the pathogenesis of T1DM will further provide the theoretical evidences and explore new targets and new ideas for the treatment of T1DM.

参考文献/References:

[1] Kleffel S, Vergani A, Tezza S, et al. Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance toislet autoantigens[J].Diabetes, 2015,64(1):158-171. DOI: 10.2337/db13-1639.
[2] Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function[J].Immunity,2015,42(4):607-612.DOI: 10.1016/j.immuni.2015.04.005.
[3] Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease[J].Immunol Rev,2014,259(1):259-272. DOI: 10.1111/imr.12176.
[4] Tedder TF. B10 cells: a functionally defined regulatory B cell subset[J].J Immunol,2015,194(4):1395-1401. DOI: 10.4049/jimmunol.1401329.
[5] Liu J, Zhan W, Kim CJ, et al. IL-10-producing B cells are induced early in HIV-1 infection and suppress HIV-1-specific T cell responses[J].PLoS One,2014,9(2):e89236. DOI: 10.1371/journal.pone.0089236.
[6] Menon M, Blair PA, Isenberg DA,et al. A regulatory feedback between plasmacytoid dendritic cells and regulatory B cells is aberrant in systemic lupus erythematosus[J].Immunity,2016,44(3):683-697. DOI: 10.1016/j.immuni.2016.02.012.
[7] Tadmor T, Zhang Y, Cho HM,et al. The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model[J].Cancer Immunol Immunother,2011,60(5):609-619. DOI: 10.1007/s00262-011-0972-z.
[8] Carter NA, Rosser EC, Mauri C. Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis[J].Arthritis Res Ther,2012,14(1):R32. DOI: 10.1186/ar3736.
[9] Blair PA, Noren～a LY, Flores-Borja F,et al. CD19(+)CD24(hi)CD38(hi)B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients[J].Immunity,2010,32(1):129-140. DOI: 10.1016/j.immuni.2009.11.009.
[10] Miyagaki T, Fujimoto M, Sato S. Regulatory B cells in human inflammatory and autoimmune diseases: from mouse models to clinical research[J].Int Immunol,2015,27(10):495-504. DOI: 10.1093/intimm/dxv026.
[11] Tebbe B, Wilde B, Ye Z, et al. Renal transplant recipients treated with calcineurin-inhibitors lack circulating immature transitional CD19+CD24hiCD38hi regulatory B-lymphocytes[J].PLoS One,2016,11(4):e0153170. DOI: 10.1371/journal.pone.0153170.
[12] Gorosito Serrán M, Fiocca Vernengo F, Beccaria CG,et al. The regulatory role of B cells in autoimmunity, infections and cancer: perspectives beyond IL10 production[J].FEBS Lett,2015,589(22):3362-3369. DOI: 10.1016/j.febslet.2015.08.048.
[13] Kessel A, Haj T, Peri R,et al. Human CD19(+)CD25(high)B regulatory cells suppress proliferation of CD4(+)T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells[J].Autoimmun Rev,2012,11(9):670-677. DOI: 10.1016/j.autrev.2011.11.018.
[14] Lee KM, Stott RT, Zhao G,et al. TGF-β-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance[J].Eur J Immunol,2014,44(6):1728-1736. DOI: 10.1002/eji.201344062.
[15] Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases[J].Nature,2014,507(7492):366-370. DOI: 10.1038/nature12979.
[16] Wang RX, Yu CR, Dambuza IM,et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease[J].Nat Med,2014,20(6):633-641. DOI: 10.1038/nm.3554.
[17] Hinman RM, Smith MJ, Cambier JC. B cells and type 1 diabetes in mice and men[J].Immunol Lett,2014,160(2):128-132. DOI: 10.1016/j.imlet.2014.01.010.
[18] Tian J, Zekzer D, Hanssen L,et al. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice[J].J Immunol,2001,167(2):1081-1089.
[19] Hussain S, Delovitch TL. Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner[J].J Immunol,2007,179(11):7225-7232.
[20] 蒋瑞妹, 秦瑶, 许馨予, 等. 非肥胖性糖尿病(NOD)小鼠糖尿病发病过程中 B10细胞水平的研究 [J]. 中华微生物学和免疫学杂志, 2014, 11: 830-838.DOI:10.3760/cma.j.issn.0254-5101.2014.11.004.
[21] Thompson WS, Pekalski ML, Simons HZ,et al. Multi-parametric flow cytometric and genetic investigation of the peripheral B cell compartment in human type 1 diabetes[J].Clin Exp Immunol, 2014,177(3):571-85. DOI: 10.1111/cei.12362.
[22] Habib T, Funk A, Rieck M,et al. Altered B cell homeostasis is associated with type Ⅰ diabetes and carriers of the PTPN22 allelic variant[J].J Immunol,2012,188(1):487-496. DOI: 10.4049/jimmunol.1102176.
[23] Deng C, Xiang Y, Tan T, et al. Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults[J].Diabetes Care,2016,39(3):434-440. DOI: 10.2337/dc15-1765.
[24] Pescovitz MD, Greenbaum CJ, Bundy B,et al. B-lymphocyte depletion with rituximab and β-cell function: two-year results[J].Diabetes Care,2014,37(2):453-459. DOI: 10.2337/dc13-0626.
[25] Mauri C. Regulation of immunity and autoimmunity by B cells[J].Curr Opin Immunol, 2010,22(6):761-767. DOI: 10.1016/j.coi.2010.10.009.

相似文献/References:

[1]李梦歌,苏恒.开源人工胰腺在1型糖尿病中的应用[J].国际内分泌代谢杂志,2022,42(05):369.[doi:10.3760/cma.j.cn121383-20210304-03012]
　Li Mengge,Su Heng..Application of Do-it-yourself artificial pancreas in type 1 diabetes[J].International Journal of Endocrinology and Metabolism,2022,42(03):369.[doi:10.3760/cma.j.cn121383-20210304-03012]
[2]罗天谊,孙咏琪,魏莹.生长激素对1型糖尿病合并生长迟缓儿童影响的研究进展[J].国际内分泌代谢杂志,2023,43(03):203.[doi:10.3760/cma.j.cn121383-20220629-06066]
　Luo Tianyi,Sun Yongqi,Wei Ying..Effect of growth hormone in children with type 1 diabetes complicated with growth retardation[J].International Journal of Endocrinology and Metabolism,2023,43(03):203.[doi:10.3760/cma.j.cn121383-20220629-06066]
[3]任留留,陈爱荣,陆静,等.估计葡萄糖处置率在评估1型糖尿病患者胰岛素抵抗中的应用价值[J].国际内分泌代谢杂志,2023,43(03):229.[doi:10.3760/cma.j.cn121383-20220525-05055]
　Ren Liuliu,Chen Airong,Lu Jing,et al.Application value of estimating glucose disposal rate in evaluating insulin resistance in patients with type 1 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2023,43(03):229.[doi:10.3760/cma.j.cn121383-20220525-05055]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81070622, 81370939) 通信作者:张梅,Email: zhangmei@njmu.edu.cn
更新日期/Last Update: 2017-05-20